Documents

Ideas Discussions Technicals Forecast Seasonals Options

Vir Biotechnology, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Vir Biotechnology, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Data partner

Description

Reported date

Form

2025

Q2 2025

Aug 06, 2025

Transcript

Quarterly report10-Q

Slides

Earnings release8-K

Q1 2025

May 07, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025

Slides

Status Update

Jan 08, 2025

Slides

Press release

2024

Q4 2024

Feb 26, 2025

Transcript

Annual report10-K

Slides

Earnings release8-K

Status Update

Nov 19, 2024

Press release

Slides

Q3 2024

Oct 31, 2024

Slides

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 01, 2024

Quarterly report10-Q

Slides

Earnings release8-K

Goldman Sachs 45th Annual Global Healthcare Conference

Jun 12, 2024

Slides

Q1 2024

May 02, 2024

Quarterly report10-Q

Slides

Earnings release8-K

J.P. Morgan 2024 42nd Annual Healthcare Conference

Jan 10, 2024

Slides

2023

Q4 2023

Feb 22, 2024

Annual report10-K

Slides

Earnings release8-K

Q3 2023

Nov 02, 2023

Quarterly report10-Q

Slides

Earnings release8-K

Q2 2023

Aug 03, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 04, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Feb 28, 2023

Annual report10-K

2021

Q4 2021

Feb 28, 2022

Annual report10-K

2020

Q4 2020

Feb 25, 2021

Annual report10-K

2019

Q4 2019

Mar 26, 2020

Annual report10-K